Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Nov;92(6):F498-502.
doi: 10.1136/adc.2005.092734.

Patent ductus arteriosus: lack of evidence for common treatments

Carl L Bose  1 , Matthew M Laughon
Affiliations
Review

Patent ductus arteriosus: lack of evidence for common treatments

Carl L Bose et al. Arch Dis Child Fetal Neonatal Ed. 2007 Nov.

Abstract

Patent ductus arteriosus (PDA) is a common diagnosis among extremely premature infants, especially in those with lung disease. Treatments are often used to close the PDA. Despite nearly three decades of research, the question of whether the benefits of treatments to prevent ductal patency or promote closure outweigh the risks of these treatments remains unanswered. The authors rarely use treatments designed to close the PDA. This article reviews three considerations in support of this restrained approach: rates of spontaneous closure of the ductus arteriosus; adverse effect of persistent ductal patency; and benefits and risks of treatments for closure.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

Comment in

References

    1. Costeloe K, Hennessy E, Gibson A T.et al The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000106659–671. - PubMed
    1. Marshall D D, Kotelchuck M, Young T E.et al Risk factors for chronic lung disease in the surfactant era: a North Carolina population‐based study of very low birth weight infants. North Carolina Neonatologists Association. Pediatrics 19991041345–1350. - PubMed
    1. Rojas M A, Gonzalez A, Bancalari E.et al Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995126605–610. - PubMed
    1. Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population‐based study. J Pediatr Gastroenterol Nutr 200540184–188. - PubMed
    1. Clyman R I. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. J Pediatr 1996128(5 Pt 1)601–607. - PubMed

Substances